TRC093
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for TRC093, covering 2010-02-05 to 2010-02-05. Get the full timeline:
Most recent: Clinical Trial Update: Phase 1, Open-label, Dose Escalation Study of TRC093, in Patients With Locally Advanced or Metastatic Solid Tumors [Phase 1]